Ronald M. Shymko

About

Ronald M. Shymko’s research has significantly advanced our understanding of the insulin-like growth factor (IGF) system, a critical axis in growth, metabolism, and disease. His work has focused on the molecular interactions that regulate IGF bioavailability, particularly the binding of IGFs to their binding proteins. Shymko’s most cited paper, “Biosensor Measurement of the Binding of Insulin-like Growth Factors I and II and Their Analogues to the Insulin-like Growth Factor-binding Protein-3” (1996, 65 citations), pioneered the use of biosensor technology to precisely quantify these interactions. This study resolved longstanding discrepancies in reported affinities by providing accurate dissociation constants (Kd values between 0.03 and 0.5 nM) for IGF-I and IGF-II binding to IGFBP-3. By characterizing how structural modifications in IGF analogues alter binding, Shymko’s work laid a foundation for designing therapeutic agents that modulate IGF signaling. His contributions have been instrumental for researchers studying cancer, growth disorders, and metabolic diseases, offering a clearer mechanistic picture of how the IGF system is regulated at the molecular level.

Research Focus

Key Achievements

Top Papers

1. 1
   Biosensor Measurement of the Binding of Insulin-like Growth Factors I and II and Their Analogues to the Insulin-like Growth Factor-binding Protein-3

   65 citations · 1996

Key Collaborators

Contact & Links